High Potency Active Pharmaceutical Ingredients (APIs) Market Size Report 2017 ByPosted by robert jackson on August 18th, 2017 The global HPAPIs market is expected to reach USD 34.8 billion by 2025, according to a new report. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period. Browse Full Research Report with TOC on https://www.radiantinsights.com/research/high-potency-active-pharmaceutical-ingredients-apis-market In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period. Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/high-potency-active-pharmaceutical-ingredients-apis-market/request-sample Further Key Findings From the Study Suggest: • Synthetic route of High PotencyAPIs dominated the overall market in terms of revenue share as of 2016 owing to presence of large manufacturers producing these type of molecules • Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it • Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment • Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development • Oncology segment heldlargest revenue share as of 2016, due to increasing demand for anti-cancerous drugs • North America HPAPIs market held the largest market share as of 2016. Growing prevalence of chronic disease patients, and established research and development infrastructure for novel drug development are factors supporting to major share of this market • Patent expiration of major drugs in North American and European countries is anticipated to fuel market growth • Asia Pacific regional market is expected to register significant growth owing to growing investments in biotechnology sector and rapidly growing oncology market • The key players in the HPAPI market includeBristol-Myers Squibb, Sigma-Aldrich Corporation, Pfizer Incand Lonza among others • Extensive research and development activities carried out by market participants is also expected to augment the market growth About Radiant Insights Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras 201 Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States Tel: 1-415-349-0054 Toll Free: 1-888-928-9744 Like it? Share it! More by this author |